Optimizing Early Oncology Studies Through Adaptive Trial Designs

March 3, 11:45am
Outsourcing in Clinical Trials West Coast 2020
San Francisco, CA

This session will focus on how the use of adaptive trial designs can help sponsors address the unique challenges of early oncology drug development and increase the likelihood of success:

  • Challenges inherent to early phase oncology clinical trials
  • Factors to consider in design of early phase oncology studies
  • Adaptive designs for assessing early/late-onset toxicity
  • Highlight how adaptive trial designs help optimize efficiency while minimizing the number of patients treated at sub-therapeutic doses

Abie Ekangaki, PhD, Vice President, Statistical Consulting
Peter J. Larson, MD, Executive Medical Director

Schedule a meeting at OCT West Coast.